Health Care • Biotechnology: Pharmaceutical Preparations
$89.06 ▼ -0.78
(-0.87%)
MKT CAP: $7.77B • VOL: 596.1K
52W L $70 52W H $149
CASH DIVIDEND YIELD
0.00%
ANNUAL RATE: $0.00 / SH
TOTAL SHAREHOLDER YIELD
1.85%
BUYBACK YIELD: 1.85%
FCF PAYOUT COVERAGE RATIO
0.0%
GAAP EPS PAYOUT: 0.0%
DIVIDEND SAFETY SCORE NO DIVIDEND
50/100
GROWTH STREAK: 0 CONSECUTIVE YRS
ABVX // EX-DIVIDEND & CAPITAL DISTRIBUTION SCHEDULE (DIV <GO>)
SPOT: $89.06
Abivax SA (ABVX) DOES NOT CURRENTLY DISTRIBUTE A REGULAR CASH DIVIDEND. CAPITAL ALLOCATION PRIORITIZES INTERNAL R&D (9.9% ROIC) AND OPPORTUNISTIC SHARE REPURCHASES (1.85% BUYBACK YIELD).